This is a beta version of OpenPrescribing Hospitals for testing and feedback purposes. Data and functionality may be incomplete. Please contact us if you find any issues or have feedback. Sign up for email alerts to stay updated.

Research

Latest Research

Published

OpenPrescribing Hospitals, an Open Access Analytics Platform for Hospital Medicines Use in England: Development and Implementation Study

Development and implementation of an open access analytics platform for hospital medicines use in England.

Published

PB2626 Anticoagulation Stewardship: Measuring Best Value Direct Oral Anticoagulant Use in the National Health Service in England using OpenPrescribing Hospitals

A publicly available measure on the OpenPrescribing Hospitals platform for best value direct oral anticoagulants (DOACs) issued in the NHS in England in secondary care.

Research and Practice in Thrombosis and Haemostasis
Read full paper
Preprint

Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019–2024: a descriptive observational study using OpenPrescribing Hospitals

A descriptive observational study of CDK4/6 inhibitor (palbociclib, ribociclib, and abemaciclib) uptake and dose reduction in NHS trusts in England, using OpenPrescribing Hospitals

Published Papers

Published

OpenPrescribing Hospitals, an Open Access Analytics Platform for Hospital Medicines Use in England: Development and Implementation Study

Development and implementation of an open access analytics platform for hospital medicines use in England.

Published

PB2626 Anticoagulation Stewardship: Measuring Best Value Direct Oral Anticoagulant Use in the National Health Service in England using OpenPrescribing Hospitals

A publicly available measure on the OpenPrescribing Hospitals platform for best value direct oral anticoagulants (DOACs) issued in the NHS in England in secondary care.

Research and Practice in Thrombosis and Haemostasis
Read full paper
Published

Impact of the pancreatic enzyme replacement therapy (PERT) shortage on prescribing in England: Analysis of national data

An analysis of national prescribing data in England to assess the impact of the pancreatic enzyme replacement therapy (PERT) shortage, beginning in June 2023, on prescribing, with validation using OpenPrescribing and OpenPrescribing Hospitals.

British Journal of Clinical Pharmacology
Read full paper
Published

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England

This study explored trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS Trusts in England.

Preprints

Preprint

Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019–2024: a descriptive observational study using OpenPrescribing Hospitals

A descriptive observational study of CDK4/6 inhibitor (palbociclib, ribociclib, and abemaciclib) uptake and dose reduction in NHS trusts in England, using OpenPrescribing Hospitals

Preprint

Trends and variations in Lithium usage across care settings in England between 2015-2024

An analysis of primary and secondary care prescribing data in England to explore trends in the use of lithium in England between 2015-2024.